Perizam 2mg/ml oral suspension
BNF presentation 040801060BEAACS within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040801060BEAACS
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
141
NHS spend (£)
£23,882.31
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 22 |
| December 2024 | 6 |
| November 2024 | 23 |
| October 2024 | 25 |
| August 2024 | 1 |
| July 2024 | 21 |
| July 2021 | 6 |
| June 2021 | 8 |
| December 2020 | 12 |
| November 2020 | 17 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
|
Modality Partnership (awc)
ODS B83033
|
4 | 36J - WEST YORKSHIRE ICB |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |